[Echocardiographic evaluation of associated @entity340 in XXXX ].

@entity1 @entity339 @entity10710 @entity850 @entity886 @entity472 @entity3454 @entity997 @entity337 @entity4794 @entity340 @entity36938
OBJECTIVE: When @entity4794 is associated with other @entity340 , diagnosis, prognosis and the treatment strategies are affected. @entity3454 may occur in some pathological settings that affect mitral apparatus. We investigated the incidence of @entity340 including @entity3454 that accompany @entity4794 and assessed the relation between echocardiographic measures. METHODS: Two hundred and one @entity1 (31 male, 170 female) between 16 and 72 years of age (mean age 40.9+/-11.4 years) with @entity4794 were included in the study. @entity1 were divided into three groups according to the mitral valve area obtained by echocardiography using planimetric method as Group I (MVA<1.1 cm(2)), Group II ( @entity36938 .1-1.5 cm(2)) and Group III ( @entity36938 .5 cm2). RESULTS: @entity4794 with @entity339 , @entity337 , @entity472 , combined @entity886 , @entity997 and @entity10710 were found in 117 (58.2%), 84 (41.8%), 18 (9%), 9 (4.5%), 62 (30.8%) and 6 (3%) @entity1 , respectively. Twenty- three @entity1 (11.4%) had @entity3454 in only anterior leaflet. Nobody of @entity1 had @entity3454 . Age, gender, rhythm, degree of @entity850 , degree of mitral and aortic regurgitations, mean pressure gradient, left atrial diameter, ejection fraction and valve score did not differ in @entity1 with and without @entity3454 . CONCLUSION: Our study has shown that @entity340 including @entity3454 frequently accompany @entity4794 and the incidence of @entity3454 in @entity1 with @entity4794 is high.
